The Value of Lung Ultrasound Score and Diaphragm Ultrasound Combined with Routine Indicators in Predicting ARDS in Children with Severe Pneumonia
-
摘要:
目的 探究肺部超声评分(LUS)、膈肌超声联合常规指标预测小儿重症肺炎(SP)并发急性呼吸窘迫综合征(ARDS)的价值。 方法 选取2022年8月至2023年8月昆明市儿童医院SP患儿160例,均行肺部超声、膈肌超声检查获取LUS、膈肌超声参数[膈肌移动度(DM)、膈肌厚度变化率(TF)],根据SP患儿住院期间是否并发ARDS分为ARDS组67例和非ARDS组93例,比较两组入院时一般资料、血清炎症因子水平、LUS、膈肌超声参数,分析SP患儿并发ARDS的影响因素,并分析LUS、膈肌超声参数预测SP患儿并发ARDS的价值。 结果 SP患儿住院期间ARDS发生率为41.88%(67/160);ARDS组入院时APS、APACHEⅡ评分、血清C反应蛋白(CRP)、白介素-6(IL-6)、高迁移率族蛋白B1(HMGB1)水平、LUS、DM高于非ARDS组,TF低于非ARDS组(P < 0.05);入院时APS、APACHEⅡ评分及血清CRP、IL-6、HMGB1水平、LUS、DM、TF均为SP患儿并发ARDS的影响因素(P < 0.05);LUS、DM、TF预测ARDS的曲线下面积(AUC)分别为0.718、0.742、0.720;常规预测方案(入院时APS、APACHEⅡ评分及血清CRP、IL-6、HMGB1水平联合)的AUC为0.852,新预测方案(常规预测方案基础上联合LUS、DM、TF)的AUC为0.930,新预测方案的AUC明显大于常规预测方案的AUC(P < 0.05)。 结论 LUS、膈肌超声参数DM、TF与SP患儿并发ARDS显著相关,联合常规指标可为临床预测SP患儿并发ARDS提供可靠依据。 Abstract:Objective To explore the value of lung ultrasound score (LUS) and diaphragm ultrasound combined with routine indicators in predicting the occurrence of acute respiratory distress syndrome (ARDS) in children with severe pneumonia (SP). Methods A total of 160 patients with SP were selected from Kunming Children’s Hospital from August 2022 to August 2023, all of whom underwent lung ultrasound and diaphragm ultrasound examination to obtain LUS and diaphragm ultrasound parameters [diaphragm mobility (DM), diaphragm thickness change rate (TF)]. The patients with SP were divided into ARDS group and non-ARDS group according to whether they were complicated with ARDS during hospitalization. The general data, serum inflammatory factor levels, LUS and diaphragm ultrasound parameters were compared between the two groups at admission, and the influencing factors of ARDS in children with SP were analyzed, and the value of LUS and diaphragm ultrasound parameters in predicting ARDS in children with SP was analyzed. Results The incidence of ARDS in SP patients was 41.88% (67/160). APS, APACHEⅡ scores, serum C-reactive protein (CRP), interleukin-6 (IL-6), high mobility group protein B1 (HMGB1) levels, LUS and DM in ARDS group were higher than those in non-ARDS group, TF were lower than those in non-ARDS group (P < 0.05). APS, APACHEⅡ scores, serum CRP, IL-6, HMGB1 levels, LUS, DM, TF were the influencing factors of ARDS in SP children at admission (P < 0.05). The area under the curve (AUC) of LUS, DM and TF predicted ARDS were 0.718, 0.742 and 0.720, respectively. The AUC of the conventional prediction scheme (APS, APACHEⅡ score combined with serum CRP, IL-6 and HMGB1 levels at admission) was 0.852, while that of the new prediction scheme (combined with LUS, DM and TF based on the conventional prediction scheme) was 0.930. The AUC of the new prediction scheme was significantly higher than that of the conventional prediction scheme (P < 0.05). Conclusion LUS, DM, TF, and SP parameters of the diaphragm are significantly correlated with ARDS in children with SP, and the combination of routine indicators can provide reliable evidence for clinical prediction of ARDS in children with SP. -
表 1 两组入院时一般资料及血清炎症因子水平比较[($ \bar x \pm s $)/n(%)]
Table 1. Comparison of general information and serum levels of inflammatory factors between the two groups at admission [($ \bar x \pm s $)/n(%)]
项目 ARDS组(n=67) 非ARDS组(n=93) t/χ2 P 性别 0.417 0.519 男 43(64.18) 55(59.14) 女 24(35.82) 38(40.86) 年龄(岁) 7.82±1.15 8.03±1.22 1.100 0.273 体重指数(kg/m2) 16.95±1.46 17.28±1.71 1.279 0.203 患病至就诊时间(d) 3.10±0.78 2.93±0.73 1.412 0.160 既往肺部感染病史 0.596 0.440 有 14(20.90) 15(16.13) 无 53(79.10) 78(83.87) 病原菌类型 0.206 0.902 革兰阴性菌 45(67.16) 60(64.52) 革兰阳性菌 21(31.34) 32(34.41) 真菌 1(1.49) 1(1.08) 机械通气 0.282 0.596 是 28(41.79) 35(37.63) 否 39(58.21) 58(62.37) 心率(次/min) 162.39±14.71 157.86±15.24 1.882 0.062 呼吸频率(次/min) 68.31±6.42 67.79±6.25 0.513 0.608 体温(℃) 39.01±0.85 38.84±0.81 1.283 0.201 APS(分) 22.17±4.36 19.45±3.94 4.119 <0.001* APACHEⅡ评分 21.53±1.95 19.29±1.13 9.154 <0.001* 白细胞计数(×109/L) 11.25±2.56 10.58±2.21 1.770 0.079 血小板计数(×109/L) 172.28±35.46 181.59±37.02 1.597 0.112 CRP(mg/L) 41.26±10.53 32.49±9.21 5.594 <0.001* IL-6(pg/mL) 82.39±16.78 65.87±14.35 6.689 <0.001* HMGB1(μg/L) 138.72±25.19 110.46±21.41 7.646 <0.001* *P < 0.05。 表 2 两组入院时LUS及膈肌超声参数比较($ \bar x \pm s $)
Table 2. Comparison of LUS and diaphragm ultrasound parameters between the two groups at admission ($ \bar x \pm s $)
组别 n LUS(分) DM(cm) TF(%) ARDS组 67 20.15±3.26 1.41±0.34 37.24±3.65 非ARDS组 93 17.48±2.51 1.12±0.28 41.08±4.13 t 5.852 5.905 6.087 P <0.001* <0.001* <0.001* *P < 0.05。 表 3 SP患儿并发ARDS的影响因素分析
Table 3. Analysis of influencing factors of ARDS in children with SP
变量 β SE Wald OR 95%CI P 下限 上限 APS 0.275 0.097 8.024 1.316 1.185 1.462 <0.001* APACHEⅡ 0.207 0.075 7.618 1.230 1.129 1.340 <0.001* CRP 0.251 0.089 7.925 1.285 1.164 1.418 <0.001* IL-6 0.301 0.098 9.409 1.351 1.201 1.519 <0.001* HMGB1 0.233 0.084 7.676 1.262 1.150 1.385 <0.001* LUS 0.380 0.112 11.487 1.462 1.302 1.641 <0.001* DM 0.318 0.096 10.946 1.374 1.228 1.537 <0.001* TF −0.118 0.041 8.243 0.889 0.813 0.972 <0.001* *P < 0.05。 表 4 LUS、膈肌超声参数预测SP患儿并发ARDS的价值
Table 4. Value of LUS and diaphragm ultrasound parameters in predicting ARDS in children with SP
指标 AUC 95%CI 截断值 敏感度(%) 特异度(%) LUS 0.718 0.641~0.786 19.02分 68.66 69.89 DM 0.742 0.668~0.809 1.33 cm 73.13 75.27 TF 0.720 0.644~0.788 38.50% 64.18 73.12 表 5 不同预测方案的预测SP患儿并发ARDS的价值比较
Table 5. Comparison of the value of different prediction schemes in predicting ARDS in children with SP
成对对比 AUC差异 标准误差 95%CI上限 95%CI下限 Z P 新预测方案vs常规预测方案 0.079 0.032 0.141 0.014 2.400 0.016* *P < 0.05。 -
[1] Purimahua S L,Arsin A A,Daud A,et al. Biomarkers of pneumonia disease in under five children in "grill culture"[J]. Gac Sanit,2021,35[Suppl 2(1)]:S435-S437. [2] 中国妇幼保健协会儿童变态反应专业委员会,《中国实用儿科杂志》编辑委员会. 儿童重症肺炎临床预警及早期决策专家共识[J]. 中国实用儿科杂志,2023,38(3):177-182. [3] Xiong F,Jiang K Y,Chen J N,et al. Metabolomics study revealing purines as potential diagnostic biomarkers of acute respiratory distress syndrome in patients with community-acquired pneumonia[J]. J Proteome Res,2023,22(8):2558-2569. doi: 10.1021/acs.jproteome.2c00788 [4] Beitler J R,Thompson B T,Baron R M,et al. Advancing precision medicine for acute respiratory distress syndrome[J]. Lancet Respir Med,2022,10(1):107-120. doi: 10.1016/S2213-2600(21)00157-0 [5] 余岳芬,刘振华,廖海燕,等. 血清miR-92a和miR-146a表达水平联合肺部超声评分预测ARDS严重程度及预后的价值[J]. 中华危重病急救医学,2020,32(10):1231-1235. doi: 10.3760/cma.j.cn121430-20200409-00268 [6] Raimondi F,Migliaro F,Corsini I,et al. Lung ultrasound score progress in neonatal respiratory distress syndrome[J]. Pediatrics,2021,147(4):e2020030528. doi: 10.1542/peds.2020-030528 [7] 张艳,李艳. 床旁超声测量膈肌移动度在儿科肺炎中的诊断价值分析[J]. 影像研究与医学应用,2023,7(8):37-39. doi: 10.3969/j.issn.2096-3807.2023.08.012 [8] 中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学,2016,36(2):97-107. doi: 10.3969/j.issn.1002-1949.2016.02.001 [9] 许峰,王荃,钱素云. 2015年版“儿童急性呼吸窘迫综合征: 儿童急性肺损伤会议共识推荐”指南解读[J]. 中华儿科杂志,2016,54(5):323-326. doi: 10.3760/cma.j.issn.0578-1310.2016.05.003 [10] Rouby J J,Arbelot C,Gao Y,et al. Training for lung ultrasound score measurement in critically Ill patients[J]. Am J Respir Crit Care Med,2018,198(3):398-401. doi: 10.1164/rccm.201802-0227LE [11] Okumura K,Latifi R,Smiley A,et al. Direct peritoneal resuscitation (DPR) improves acute physiology and chronic health evaluation (APACHE) IV and acute physiology score when used in damage control laparotomies: Prospective cohort study on 37 patients[J]. Surg Technol Int,2022,41(1):sti41/1620. [12] Shang X K,Wang Y G. Comparison of outcomes of high-flow nasal cannula and noninvasive positive-pressure ventilation in patients with hypoxemia and various APACHE II scores after extubation[J]. Ther Adv Respir Dis,2021,15(1): 17534666211004235. [13] 刘晓晖,高洪亮,白雪. 肺部超声检查联合PCT、CRP检测在重症肺炎并发ARDS患者中的应用价值[J]. 医学临床研究,2022,39(5):701-704. doi: 10.3969/j.issn.1671-7171.2022.05.017 [14] 陈若红,冯业成,黄惠敏,等. 儿童肺部感染并发急性呼吸窘迫综合征影响因素分析[J]. 中国妇幼健康研究,2022,33(5):67-71. doi: 10.3969/j.issn.1673-5293.2022.05.012 [15] Kazi S,Hernstadt H,Abo Y N,et al. The utility of chest x-ray and lung ultrasound in the management of infants and children presenting with severe pneumonia in low-and middle-income countries: A pragmatic scoping review[J]. J Glob Health,2022,12(1):10013. [16] Gil-Rodr í guez J,Martos-Ruiz M,Benavente-Fernández A,et al. Lung ultrasound score severity cut-off points in COVID-19 pneumonia. A systematic review and validating cohort[J]. Med Clin (Barc),2023,160(12):531-539. doi: 10.1016/j.medcli.2023.01.024 [17] 朱晶,何珊. 肺超声评分在感染性肺炎患儿病情评估中的应用分析[J]. 山西医药杂志,2023,52(8):600-602. doi: 10.3969/j.issn.0253-9926.2023.08.009 [18] Espersen C,Platz E,Skaarup K G,et al. Lung Ultrasound Findings Associated With COVID-19 ARDS,ICU Admission,and All-Cause Mortality[J]. Respir Care,2022,67(1):66-75. doi: 10.4187/respcare.09108 [19] Wang J,Yang X F,Zhou B R,et al. Review of Machine Learning in Lung Ultrasound in COVID-19 Pandemic[J]. J Imaging,2022,8(3):65. doi: 10.3390/jimaging8030065 [20] 魏纯玲,王洪锦,聂诗雨,等. 肺部超声评分联合血管外肺水指数、血清生长分化因子15对ARDS患者病情严重程度及预后的评估价值[J]. 山东医药,2023,63(10):84-87. doi: 10.3969/j.issn.1002-266X.2023.10.021 [21] 吴军,吴怀标. 肺部超声、机械功与重症肺炎肺水肿及ARDS关系分析[J]. 影像科学与光化学,2022,40(1):142-146. doi: 10.7517/issn.1674-0475.210722 [22] 王元丽,邱伟. 膈肌移动度与床旁超声心动图在新生儿肺炎中的应用研究[J]. 国际呼吸杂志,2022,42(14):1058-1062. doi: 10.3760/cma.j.cn131368-20220223-00123 [23] 肖俊飞,蒋慧,李军建,等. 膈肌超声评估早产儿呼吸功能的应用价值[J]. 临床超声医学杂志,2023,25(10):791-794. doi: 10.3969/j.issn.1008-6978.2023.10.008 [24] 黄园琴,杨佳,左文霞,等. 膈肌超声预测心脏术后急性呼吸窘迫综合征患者撤机的临床研究[J]. 重庆医学,2022,51(14):2401-2404+2409. doi: 10.3969/j.issn.1671-8348.2022.14.014 [25] 何敏. 重症肺炎合并呼吸窘迫综合征患儿血清淀粉样蛋白A和C-反应蛋白表达情况及临床应用价值[J]. 中国妇幼保健,2023,38(24):4868-4871. [26] 李成,何浩,夏凤强,等. 外周血炎症因子水平与重症肺炎并发急性呼吸窘迫综合征相关性分析[J]. 中国煤炭工业医学杂志,2021,24(1):67-71. -